ZVRA EBITDA
Zevra Therapeutics Inc · EBITDA
ZVRA EBITDA
Latest reported$73.06Mperiod ending
ZVRA TTM EBITDA (-$18.47M → $73.06M)
TTM EBITDA
High-resolution chart · PNG
ZVRA ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 73,061,000 | |
| 140,469,000 | |
| 98,709,000 | |
| 67,207,000 | |
| 36,445,000 | |
| -60,304,000 | |
| -76,400,000 | |
| -73,484,000 | |
| -57,628,000 | |
| -43,817,000 | |
| -42,481,000 | |
| -37,608,000 | |
| -30,295,000 | |
| -52,463,000 | |
| -41,202,000 | |
| -35,065,000 | |
| -30,626,000 | |
| 206,000 | |
| -7,879,000 | |
| -8,457,000 | |
| -8,004,000 | |
| -11,598,000 | |
| -5,343,000 | |
| -6,271,000 | |
| -1,726,000 | |
| -12,078,000 | |
| -19,137,000 | |
| -18,401,000 | |
| -35,070,000 | |
| -35,556,000 | |
| -49,181,000 | |
| -54,489,000 | |
| -49,189,000 | |
| -45,653,000 | |
| -35,756,000 | |
| -35,119,000 | |
| -38,620,000 | |
| -43,262,000 | |
| -30,151,000 | |
| -30,118,000 | |
| -27,095,000 | |
| -46,441,000 | |
| -49,975,000 | |
| -49,435,264 | |
| -47,405,264 | |
| -21,509,264 | |
| -18,466,264 | |
| -12,177,423 |